| Date | Time | Source | Headline | Symbol | Company |
| 06/05/2024 | 7:41AM | IH Market News | Apollo Buys 49% of Intel’s Irish Plant for $11bn, BlackRock and Citadel to Create Texas Exchange, and More News | NYSE:JNJ | Johnson and Johnson |
| 06/04/2024 | 4:30PM | Business Wire | Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results | NYSE:JNJ | Johnson and Johnson |
| 05/31/2024 | 8:45AM | Business Wire | Johnson & Johnson Completes Acquisition of Shockwave Medical | NYSE:JNJ | Johnson and Johnson |
| 05/29/2024 | 5:48PM | PR Newswire (US) | Sarepta Therapeutics Set to Join S&P MidCap 400 | NYSE:JNJ | Johnson and Johnson |
| 05/28/2024 | 4:10PM | Edgar (US Regulatory) | Form SD - Specialized disclosure report | NYSE:JNJ | Johnson and Johnson |
| 05/28/2024 | 7:35AM | GlobeNewswire Inc. | Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis | NYSE:JNJ | Johnson and Johnson |
| 05/28/2024 | 7:30AM | Business Wire | Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis | NYSE:JNJ | Johnson and Johnson |
| 05/22/2024 | 12:05PM | Business Wire | Proposed Class Action Filed by Six Law Firms Alleging Series of Fraudulent Transfers by Johnson & Johnson in Talc Litigation | NYSE:JNJ | Johnson and Johnson |
| 05/21/2024 | 10:43AM | Edgar (US Regulatory) | Form CERT - Certification by an exchange approving securities for listing | NYSE:JNJ | Johnson and Johnson |
| 05/20/2024 | 5:17PM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NYSE:JNJ | Johnson and Johnson |
| 05/20/2024 | 4:34PM | Edgar (US Regulatory) | Form 8-A12B - Registration of securities [Section 12(b)] | NYSE:JNJ | Johnson and Johnson |
| 05/20/2024 | 4:01PM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:JNJ | Johnson and Johnson |
| 05/20/2024 | 9:31AM | Edgar (US Regulatory) | Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities | NYSE:JNJ | Johnson and Johnson |
| 05/17/2024 | 11:21AM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:JNJ | Johnson and Johnson |
| 05/17/2024 | 7:36AM | IH Market News | OpenAI’s Reddit Partnership Boosts Shares by 14%, Microsoft Embraces AMD Chips for AI, and More News | NYSE:JNJ | Johnson and Johnson |
| 05/16/2024 | 4:16PM | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | NYSE:JNJ | Johnson and Johnson |
| 05/16/2024 | 7:30AM | Business Wire | Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment | NYSE:JNJ | Johnson and Johnson |
| 05/14/2024 | 5:01PM | Edgar (US Regulatory) | Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses | NYSE:JNJ | Johnson and Johnson |
| 05/14/2024 | 7:26AM | IH Market News | Walmart Corporate Job Cuts and Office Centralization, GameStop and AMC Surge, and More News | NYSE:JNJ | Johnson and Johnson |
| 05/14/2024 | 6:05AM | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NYSE:JNJ | Johnson and Johnson |
| 05/13/2024 | 8:36AM | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NYSE:JNJ | Johnson and Johnson |
| 05/10/2024 | 5:14PM | Edgar (US Regulatory) | Form 13F-HR - Quarterly report filed by institutional managers, Holdings | NYSE:JNJ | Johnson and Johnson |
| 05/08/2024 | 4:30PM | Business Wire | Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference | NYSE:JNJ | Johnson and Johnson |
| 05/06/2024 | 4:05PM | GlobeNewswire Inc. | Shockwave Medical Reports First Quarter 2024 Financial Results | NYSE:JNJ | Johnson and Johnson |
| 05/01/2024 | 6:30AM | Business Wire | Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization | NYSE:JNJ | Johnson and Johnson |
| 04/22/2024 | 4:30PM | Business Wire | Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC) | NYSE:JNJ | Johnson and Johnson |
| 04/19/2024 | 7:31AM | IH Market News | Paramount’s Shares Surge Following Sony and Apollo’s Joint Bid; ISS Backs Berkshire Hathaway Director Re-election, and More | NYSE:JNJ | Johnson and Johnson |
| 04/17/2024 | 6:59AM | IH Market News | US Index Futures See Gains, Oil Prices Dip | NYSE:JNJ | Johnson and Johnson |
| 04/16/2024 | 4:33PM | IH Market News | U.S. Stocks Finish Lackluster Session Narrowly Mixed | NYSE:JNJ | Johnson and Johnson |
| 04/16/2024 | 10:46AM | Business Wire | CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results | NYSE:JNJ | Johnson and Johnson |